Ipca Laboratories Market Cap

Ipca Laboratories has a market cap or net worth of 389.94 billion as of April 28, 2026. Its market cap has increased by 9.84% in one year.

Market Cap

389.94B

Enterprise Value

404.57B

Revenue

95.06B

Ranking

n/a

PE Ratio

42.86

Stock Price

1,539.10

Market Cap Chart

Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 389.94B, an increase of 12,014.75%. That is a compound annual growth rate of 22.23%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	389.94B	8.32%
Dec 31, 2025	359.98B	-16.30%
Dec 31, 2024	430.08B	52.29%
Dec 29, 2023	282.41B	32.03%
Dec 30, 2022	213.90B	-22.18%
Dec 31, 2021	274.86B	-1.01%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GlaxoSmithKline Pharmaceuticals	418.95B
J. B. Chemicals & Pharmaceuticals	321.75B
Abbott India	535.45B
AstraZeneca Pharma India	212.54B
Granules India	170.76B
Rubicon Research	154.65B
Jubilant Pharmova	149.60B
Lupin	1,049.73B

Market Cap Rankings